References and Notes
<A NAME="RU11606ST-1A">1a</A>
Hoshino O.
The Alkaloids
Vol. 51:
Cordell GA.
Academic Press;
New York:
1998.
p.323-424
<A NAME="RU11606ST-1B">1b</A>
Marco-Contelles J.
Carreiras MDC.
Rodríguez C.
Villarroya M.
García AG.
Chem. Rev.
2006,
106:
116
<A NAME="RU11606ST-2A">2a</A>
Santavy F.
The Alkaloids
Vol. 17:
Manske RHF.
Rodorico RGA.
Academic Press;
New York:
1979.
p.385-519
<A NAME="RU11606ST-2B">2b</A>
Trost BM.
Tang W.
Toste D.
J. Am. Chem. Soc.
2005,
127:
14785
<A NAME="RU11606ST-3A">3a</A>
Poupat C.
Husson H.-P.
Das BC.
Bladon P.
Potier P.
Tetrahedron
1972,
28:
3103
<A NAME="RU11606ST-3B">3b</A>
Husson H.-P.
Poupat C.
Rodriguez B.
Potier P.
Tetrahedron
1973,
29:
1405
<A NAME="RU11606ST-3C">3c</A>
Nagao Y.
Takao S.
Miyasaka T.
Fujita E.
J. Chem. Soc., Chem. Commun.
1981,
286
<A NAME="RU11606ST-3D">3d</A>
Hamilton CJ.
Fairlamb AH.
Eggleston IM.
J. Chem. Soc., Perkin Trans. 1
2002,
1115
<A NAME="RU11606ST-3E">3e</A>
Hamilton CJ.
Saravanamuthu A.
Fairlamb AH.
Eggleston IM.
Bioorg. Med. Chem.
2003,
11:
3683
<A NAME="RU11606ST-3F">3f</A>
Hamilton CJ.
Saravanamuthu A.
Poupat C.
Fairlamb AH.
Eggleston IM.
Bioorg. Med. Chem.
2006,
14:
2266
<A NAME="RU11606ST-4">4</A>
Laronze J.-Y.
Boukili RE.
Royer D.
Lévy J.
Tetrahedron
1991,
47:
10003
<A NAME="RU11606ST-5">5</A>
Kaminsky D.
Shavel J.
Meltzer RI.
Tetrahedron Lett.
1967,
859
<A NAME="RU11606ST-6A">6a</A>
Miyata O.
Takeda N.
Morikami Y.
Naito T.
Org. Biomol. Chem.
2003,
1:
254
<A NAME="RU11606ST-6B">6b</A>
Miyata O.
Takeda N.
Naito T.
Org. Lett.
2004,
6:
1761
<A NAME="RU11606ST-7">7</A>
The stereostructure of compound 6a was established as cis-isomer by NOESY of 1H NMR spectra while stereostructures of 6b and 6c have not been established.
<A NAME="RU11606ST-8">8</A>
The compounds 7a-c were obtained as a mixture of two diastereomers and found to be 4a,9b-cis-configuration, but relative configuration at 4-position is not established.
<A NAME="RU11606ST-9">9</A>
Reaction of 5b with TFAA.
To a solution of oxime ether 5b (47 mg, 0.18 mmol) in CH2Cl2 (1.8 mL) was added TFAA (0.050 mL, 0.36 mmol) under a nitrogen atmosphere at r.t.
After being stirred at the same temperature for 4 h, the reaction mixture was concentrated
at reduced pressure. Purification of the residue by medium-pressure column chromatography
(n-hexane-EtOAc, 5:1) afforded ethyl 4a-(2,2,2-trifluoroacetamido)-1,2,3,4,4a,9b-hexahydro-9b-dibenzofurancarboxylate
(6b, 50 mg, 78%) as colorless crystals, mp 39-41 °C (hexane). 1H NMR (500 MHz, CDCl3): δ = 8.70 (1 H, br s), 7.24 (1 H, br d, J = 8 Hz), 7.23 (1 H, br td, J = 8, 1 Hz), 6.98 (1 H, td, J = 8, 1 Hz), 6.95 (1 H, br d, J = 8 Hz), 4.37-4.27 (2 H, m), 2.87 (1 H, br dt, J = 15, 5 Hz), 2.39 (1 H, br dt, J = 15, 5 Hz), 2.30 (1 H, br ddd, J = 15, 10, 5 Hz), 1.71-1.51 (5 H, m), 1.34 (3 H, t, J = 7 Hz), 13C NMR (125 MHz, CDCl3): δ = 172.7, 156.5, 156.1 (q, COCF3), 130.8, 129.5, 123.8, 122.1, 115.4 (q, CF3), 111.7, 97.4, 62.6, 57.9, 35.3, 30.0, 20.8, 20.7, 14.0. IR (CHCl3): 3380, 1741 cm-1. HRMS (EI): m/z calcd for C17H18F3NO4 [M+]: 357.1187; found: 357.1196.
Reaction of 5b with TFAT in the Presence of DMAP.
To a solution of oxime ether 5b (47 mg, 0.18 mmol) in CH2Cl2 (1.8 mL) were added DMAP (66 mg, 0.54 mmol) and TFAT (0.13 mL, 0.90 mmol) under a
nitrogen atmosphere at r.t. After being stirred at the same temperature for 24 h,
the reaction mixture was diluted with H2O and extracted with CHCl3. The organic phase was washed with H2O, dried over MgSO4 and concentrated at reduced pressure. Purification of the residue by medium-pressure
column chromatography (n-hexane-EtOAc, 7:1) afforded ethyl 1,2,3,4-tetrahydro-4-dibenzofurancarboxylate (8b, 28 mg, 64%) as a colorless oil. 1H NMR (500 MHz, CDCl3): δ = 7.44 (1 H, br t, J = 8.0 Hz), 7.43 (1 H, br d, J = 8.0 Hz), 7.24 (1 H, br dd, J = 8.0, 1.0 Hz), 7.20 (1 H, br td, J = 8.0, 1.0 Hz), 4.25-4.20 (2 H, m), 3.85 (1 H, br tt, J = 6.0, 2.0 Hz), 2.72 (1 H, br dtd, J = 15.0, 6.0, 2.0 Hz), 2.63 (1 H, br dddd, J = 15.0, 7.5, 6.0, 2.0 Hz), 2.25 (1 H, br dddd, J = 13.0, 7.5, 6.0, 2.5 Hz), 2.13 (1 H, br dddd, J = 13.0, 10.0, 6.0, 3.0 Hz), 2.02-1.98 (1 H, m), 1.87 (1 H, br dddd, J = 16.0, 7.5, 6.0, 3.0 Hz), 1.29 (3 H, t, J = 7 Hz). 13C NMR (125 MHz, CDCl3): δ = 172.3, 154.7, 149.5, 128.2, 123.8, 122.3, 118.9, 115.3, 111.2, 61.2, 40.6,
27.2, 20.6, 20.3, 14.2. IR (CHCl3): 1731 cm-1. HRMS (EI): m/z calcd for C15H16O [M+]: 244.1098; found: 244.1107.